Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Kura Oncology, Inc. KURA

Full chart Compare
Set alert

Price alert · KURA

All alert types
7.62 USD -0.11 (-1.42%)

Nov 12, 2026, 10:14 AM EST

7.52 Day range 7.73
6.75 52-week range 13.90
YTD
-26.66%
1 year
-28.65%

Financial health

Altman Z-Score

-3.46 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -3.3×
FY 2016: -4.0×FY 2017: -10.1×FY 2018: -8.2×FY 2019: -9.1×FY 2020: -19.3×FY 2021: -7.1×FY 2022: -6.1×FY 2023: -6.9×FY 2024: -4.3×FY 2025: -3.3×
FY 2016 5y median -6.1× FY 2025
P/S 13.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 13.9×FY 2025: 13.5×
FY 2016 5y median 0.0× FY 2025
P/B 5.2×
FY 2016: 1.9×FY 2017: 4.5×FY 2018: 3.1×FY 2019: 2.6×FY 2020: 2.8×FY 2021: 1.8×FY 2022: 2.0×FY 2023: 2.7×FY 2024: 1.8×FY 2025: 5.2×
FY 2016 5y median 2.0× FY 2025
P/FCF -12.9×
FY 2016: -4.4×FY 2017: -12.5×FY 2018: -10.2×FY 2019: -10.5×FY 2020: -24.1×FY 2021: -8.8×FY 2022: -7.5×FY 2023: -8.4×FY 2024: 5.6×FY 2025: -12.9×
FY 2016 5y median -8.4× FY 2025
EV/EBITDA -2.8×
FY 2016: -3.8×FY 2017: -9.7×FY 2018: -7.7×FY 2019: -8.3×FY 2020: -16.0×FY 2021: -6.5×FY 2022: -5.9×FY 2023: -6.9×FY 2024: -3.2×FY 2025: -2.8×
FY 2016 5y median -5.9× FY 2025
EV/Sales 11.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 10.1×FY 2025: 11.6×
FY 2016 5y median 0.0× FY 2025
FCF Yield -7.8%
FY 2016: -23.0%FY 2017: -8.0%FY 2018: -9.8%FY 2019: -9.5%FY 2020: -4.2%FY 2021: -11.4%FY 2022: -13.3%FY 2023: -11.9%FY 2024: 17.8%FY 2025: -7.8%
FY 2016 5y median -11.4% FY 2025

Profitability

Gross Margin 99.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 100.0%FY 2025: 99.9%
FY 2016 5y median 0.0% FY 2025
Operating Margin -449.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -358.5%FY 2025: -449.9%
FY 2016 5y median 0.0% FY 2025
Net Margin -412.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -322.9%FY 2025: -412.9%
FY 2016 5y median 0.0% FY 2025
ROE -160.0%
FY 2016: -48.5%FY 2017: -44.4%FY 2018: -37.5%FY 2019: -28.9%FY 2020: -14.7%FY 2021: -25.8%FY 2022: -32.3%FY 2023: -38.4%FY 2024: -42.1%FY 2025: -160.0%
FY 2016 5y median -38.4% FY 2025
ROIC -48.8%
FY 2016: -44.0%FY 2017: -41.3%FY 2018: -37.3%FY 2019: -29.7%FY 2020: -14.7%FY 2021: -25.5%FY 2022: -32.2%FY 2023: -39.9%FY 2024: -28.2%FY 2025: -48.8%
FY 2016 5y median -32.2% FY 2025
ROA -37.7%
FY 2016: -39.5%FY 2017: -37.0%FY 2018: -33.1%FY 2019: -26.1%FY 2020: -13.8%FY 2021: -24.4%FY 2022: -29.8%FY 2023: -34.0%FY 2024: -22.9%FY 2025: -37.7%
FY 2016 5y median -29.8% FY 2025

Growth (YoY)

Revenue 25.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 25.2%
FY 2016 FY 2025
Operating Income -57.2%
FY 2016: -18.9%FY 2017: -27.2%FY 2018: -74.3%FY 2019: -7.3%FY 2020: -36.2%FY 2021: -42.8%FY 2022: -6.6%FY 2023: -18.5%FY 2024: -16.5%FY 2025: -57.2%
FY 2016 FY 2025
EPS (diluted) -57.4%
FY 2016: 35.5%FY 2017: -3.4%FY 2018: -13.2%FY 2019: 12.2%FY 2020: -11.9%FY 2021: -16.6%FY 2022: -3.0%FY 2023: -2.5%FY 2024: 2.9%FY 2025: -57.4%
FY 2016 FY 2025
Free Cash Flow -152.8%
FY 2016: -40.9%FY 2017: -12.2%FY 2018: -71.1%FY 2019: -12.5%FY 2020: -31.5%FY 2021: -46.8%FY 2022: -4.7%FY 2023: -12.9%FY 2024: 207.1%FY 2025: -152.8%
FY 2016 FY 2025

Financial Health

Current Ratio 6.1×
FY 2016: 12.6×FY 2017: 9.4×FY 2018: 13.3×FY 2019: 15.4×FY 2020: 24.5×FY 2021: 23.3×FY 2022: 18.6×FY 2023: 12.3×FY 2024: 9.5×FY 2025: 6.1×
FY 2016 5y median 12.3× FY 2025
Quick Ratio 6.1×
FY 2016: 12.6×FY 2017: 9.4×FY 2018: 13.3×FY 2019: 15.4×FY 2020: 24.5×FY 2021: 23.3×FY 2022: 18.6×FY 2023: 12.3×FY 2024: 9.5×FY 2025: 6.1×
FY 2016 5y median 12.3× FY 2025
Debt / Equity 0.1×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.3×FY 2020: 3.5×FY 2021: 0.6×FY 2022: 0.3×FY 2023: 0.1×FY 2024: 1.2×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -201×
FY 2016: -49.2×FY 2017: -40.6×FY 2018: -64.8×FY 2019: -116×FY 2020: -159×FY 2021: -317×FY 2022: -611×FY 2023: -107×FY 2024: -119×FY 2025: -201×
FY 2016 5y median -201× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31